SERA2

N/A

Report date: 2023/05/18 10:03:25

NME

Base Information

Drug NameSERA2

Drug Alias NameSERA2SERA-2

ClassificationSmall molecules

Mechanisms of ActionEstrogen receptors agonists

TargetsEstrogen receptors

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSystems Oncology Llc

China Registration ClassN/A

Develop Information

Active CompaniesSystems Oncology Llc

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A